A carregar...
The use of natalizumab for multiple sclerosis
Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte trafficking into the central nervous system. It is US Food and Drug Administration (FDA) approved for the treatment of relapsing–remitting multiple sclerosis (RRMS). Natalizumab demonstrated high efficac...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499927/ https://ncbi.nlm.nih.gov/pubmed/28721050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S114636 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|